Increased serum VEGF in 13 children with Wilms' tumour falls after surgery but rising levels predict poor prognosis

Cancer Letters

Volumn 173, Issue 2, 2001, Pages 183-186

  Blann, Andrew D ^a,c   Li, Jun Ling ^a   Li, Chenggnag ^b   Kumar, Shant ^b  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Prognosis; Vascular endothelial cell growth factor; Wilms' tumour

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; MITOGENIC AGENT; VASCULOTROPIN; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; INFANT; MALE; NEPHROBLASTOMA; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; TUMOR DIFFERENTIATION; TUMOR RECURRENCE; TUMOR REGRESSION;

ADOLESCENT; ANALYSIS OF VARIANCE; CHILD; CHILD, PRESCHOOL; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; INFANT; KIDNEY NEOPLASMS; LYMPHOKINES; MALE; PROGNOSIS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; WILMS TUMOR;

EID: 0035965585     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00666-8     Document Type: Article

References (16)

1. Angiogenesis: Mechanistic insight, neovascular diseases, and therapeutic prospects
2. Vascular permeability factor/vascular endothelial growth, microvascular hyperpermeability, and angiogenesis
3. Enhancement of tumour growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells
4. Vascular permeability factor (VPF, VEGF) in tumour biology
5. Serum levels of vascular endothelial growth factor dependent on the stage progression of lung cancer
6. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: Clinical evidence of platelet scavenging?
7. Vascular endothelial growth factor (VEGF) in breast cancer: Comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen
8. Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, flt-1, in haematological cancers: A comparison with breast cancer
9. Metastasis correlates with production of vascular endothelial growth factor in a murine model of human Wilms' tumour
10. Anti-VEGF antibody suppresses primary tumour growth and metastasis in an experimental model of Wilms' tumour
11. A scoring, system for Wilms' tumour: Pathological study of the second Medical Research Council (MRC) trial
12. Serum levels of basic fibroblast growth factor and vascular endothelial growth factor in children and adolescents with type 1 diabetes mellitus
13. Stabilisation of vascular endothelial growth factor mRNA by hypoxia and hypoglycaemia and co-regulation with other ischaemia-induced genes
14. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia
15. Constitutive production and thrombin-induced release of VEGF by human megakaryocytes and platelets